ESR1 and breast carcinoma: A 21-gene reverse transcriptase-polymerase chain reaction (RT-PCR) assay, or Oncotype DX [38], has been used to grade a recurrence risk of breast cancer in patients with lymph node negative, estrogen receptor-positive breast cancer.